Evangelos Terpos to Receptor Activator of Nuclear Factor-kappa B
This is a "connection" page, showing publications Evangelos Terpos has written about Receptor Activator of Nuclear Factor-kappa B.
Connection Strength
1.047
-
Controversies in the use of new bone-modifying therapies in multiple myeloma. Br J Haematol. 2021 Jun; 193(6):1034-1043.
Score: 0.901
-
Significance of macrophage inflammatory protein-1 alpha (MIP-1alpha) in multiple myeloma. Leuk Lymphoma. 2005 Dec; 46(12):1699-707.
Score: 0.080
-
Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index. Blood. 2003 Aug 01; 102(3):1064-9.
Score: 0.066